UW Madison Genetics Colloquium - Yang Yeh

Value of the Information & Strength of the Argument

The talk provides valuable insights into the complex interactions between diet and drugs, using rigorous experimental approaches. The argumentation is solid, building from epidemiological data to controlled mouse studies, and then dissecting molecular mechanisms. The speaker clearly explains the rationale and methodology, and acknowledges limitations such as potential downsides of the diets. The use of multiple experimental models (dietary interventions, pharmacological inhibition, genetic knockouts) strengthens the conclusions. The presentation is well-structured, with clear hypotheses and logical progression.

Scientific Rigor, Source Quality, Title Accuracy

The talk demonstrates scientific rigor through the use of controlled diets, standardized phenotyping, and genetic models. The speaker references several published studies, including those by Morgan Levine, Crystal Hill, Christopher Lynch, Sean Adams, and Rich Miller, as well as the NIH’s Intervention Testing Program. The title accurately reflects the content, as it is a colloquium presentation. The description provides minimal context, but the talk itself is self-contained. The speaker does not overstate findings and discusses uncertainties, such as the ambiguous effects on muscle and heart function.

The title accurately reflects the content: a genetics colloquium presentation by Yang Yeh.

8/10

The talk presents original research from a well-established lab, with clear methodology and references to published studies. The speaker is a postdoc presenting at a university colloquium, indicating a scientific audience. The content is based on experimental data, but as a presentation, it lacks full peer-review details.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by host, Yang Yeh begins talk on diet-drug interaction.
• 01:00Introduces cheese effect: tyramine and MAO inhibitors, historical example.
• 05:00Discusses dietary protein and popular media's advice to eat more protein.
• 07:00Presents epidemiological data on protein intake and mortality, diabetes risk.
• 10:00Introduces amino acid-defined diets and low BCAA diet extending lifespan in mice.
• 13:00Shows glucose tolerance tests for low leucine, isoleucine, valine diets; low isoleucine improves glycemic control.
• 16:00Discusses effects of low isoleucine diet in aged mice: improved glucose tolerance, energy expenditure.
• 20:00Presents liver transcriptomics and proteomics, showing diet effects on aging-related genes.
• 25:00Introduces rapamycin, its mechanism, and lifespan extension effects.
• 30:00Shows combination of rapamycin and low isoleucine diet blocks diet's metabolic benefits in young mice.
• 35:00In western diet context, low isoleucine still improves glucose tolerance even with rapamycin.
• 40:00Mechanistic studies: FGF21 induction requires liver mTORC1, not mTORC2.

• Levine et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population — Epidemiological data on protein intake and mortality.
• Solon-Biet et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice — Macronutrient balance and aging in mice.
• Fontana et al. Effects of dietary protein restriction on human health — Review of protein restriction effects.
• Richardson et al. Effects of rapamycin on aging and age-related diseases — Rapamycin and lifespan extension.
• Miller et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction — Rapamycin effects in mice.
• Lamming et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity — mTORC2 and insulin resistance.
• Green et al. Role of FGF21 in the metabolic effects of dietary protein restriction — FGF21 and protein restriction.
• Maida et al. A liver stress-endocrine nexus promotes metabolic integrity — Liver stress and FGF21.

• Solon-Biet et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice — Supports the role of macronutrient balance in health.
• Lamming et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity — Explains rapamycin's effect on glucose metabolism.
• Green et al. Role of FGF21 in the metabolic effects of dietary protein restriction — FGF21 mediates effects of protein restriction.

• Some studies suggest high protein intake is beneficial for muscle mass in elderly — The talk notes a crossover effect where higher protein may be beneficial in older age, but the presented data focus on metabolic benefits of low protein.